Médicaments essentiels | WHO assessment instrument

WHO assessment instrument

Imprimer PDF

This series of reports present the results of transparency assessments carried out in Jordan, Lebanon and Syrian Arab Republic. It provides a comprehensive picture of the level of transparency and the potential vulnerability to corruption of six essential functions of the public pharmaceutical sector – registration, promotion, inspection, selection, procurement and distribution of medicines.

Measuring_transparency_to_improve_good_governance_in_the_public_pharmaceutical_sector_in_Pakistan

Measuring transparency to improve good governance in the public pharmaceutical sector in Pakistan

Thumbnail of Measuring transparency to improve good governance in the public pharmaceutical sector in Jordan

Measuring transparency to improve good governance in the public pharmaceutical sector in Jordan [pdf 109Mb]

Thumbnail of Measuring transparency to improve good governance in the public pharmaceutical sector in Lebanon

Measuring transparency to improve good governance in the public pharmaceutical sector in Lebanon [pdf 1009kb]

Thumbnail of Measuring transparency to improve good governance in the public pharmaceutical sector in the Syrian Arab Republic

Measuring transparency to improve good governance in the public pharmaceutical sector in Syrian Arab Republic [pdf 144Mb]